Nasacort (Triamcinolone Acetonide)

Nasacort (triamcinolone acetonide) is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages.

• Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea.
• Seasonal allergic nasal congestion: alleviates blockage and discharge during pollen or allergen exposure.
• Hay fever: improves overall nasal symptom control during seasonal allergen peaks.

• Triamcinolone acetonide binds to intracellular glucocorticoid receptors in nasal epithelial cells, altering gene transcription and decreasing the synthesis of pro‑inflammatory cytokines, chemokines, and arachidonic‑acid metabolites. This results in reduced vascular permeability, edema, and immune cell infiltration, providing anti‑inflammatory and anti‑edematous effects within the nasal mucosa.

Nasacort may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nasal irritation or burning sensation
• Epistaxis (nosebleeds)
• Headache
• Throat irritation or dryness
• Altered taste or bitter taste
• Cough

Serious or Rare Side Effects

• Fungal infection of the nasal mucosa (e.g., aspergillosis)
• Severe or prolonged nosebleeds
• Vision changes or cataract formation with long‑term use
• Adrenal suppression with extensive systemic absorption
• Anaphylactic or severe allergic reaction

Before initiating therapy, consider the following safety measures.

• Assess for active nasal infection: avoid use if bacterial or fungal infection is present.
• Limit duration: use only as prescribed and avoid prolonged continuous therapy without medical review.
• Monitor intra‑ocular pressure: caution in patients with glaucoma or ocular hypertension.
• Age restriction: do not use in children under 2 years unless directed by a specialist.
• Avoid concurrent nasal corticosteroids: do not combine with other intranasal steroid products.
• Store at room temperature: keep in the original packaging, protect from moisture and heat.

Nasacort can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid)

• Systemic corticosteroids: increased risk of systemic glucocorticoid effects.
• Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure.
• Live vaccines: nasal steroid may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely)

• Antihistamines: may increase nasal dryness.
• Decongestant nasal sprays: additive irritation risk.
• Antifungal nasal agents: potential alteration of local drug absorption.